Invesco Mutual Fund unveils India Pharma and Healthcare Fund

image credit- freepik

Invesco Mutual Fund has announced the launch of Invesco India Pharma and Healthcare Fund (An open ended equity scheme investing in Pharma, Healthcare and allied sectors).

The fund seeks to capitalise on India's evolving healthcare ecosystem, which is being shaped by favourable demographics, expanding healthcare access, rising insurance penetration, growing global pharmaceutical leadership, and emerging innovation-driven opportunities across healthcare and life sciences.

The scheme will invest across pharmaceutical companies, hospitals, diagnostics, contract development and manufacturing organizations (CDMOs), contract research organizations (CROs), medical devices, healthcare services, insurance and other allied healthcare segments.

The fund will be managed by Aditya Khemani and will be benchmarked against the BSE Healthcare TRI.

The minimum lumpsum investment amount during the NFO is Rs 1,000 and in multiples of Re 1 thereafter. For SIP investments, the minimum application amount is Rs 100 and in multiples of Re 1 thereafter. The fund will charge an exit load of 0.50% for units redeemed/switched out on or before 3 months from the date of allotment. No exit load will be charged if units are redeemed/switched out after 3 months.

The New Fund Offer (NFO) is open for subscription from today (August 18, 2026) and will close on September 1, 2026.